Skip to the page

Data / Form D filings / Ampel, LLC

Ampel, LLC: Form D filings

Ampel, LLC, a biotechnology company in Charlottesville, VA, filed 5 Form D notices with the SEC between 2021 and 2023. The latest, on July 6, 2023, reports $1.8 million sold of a $5 million offering to 5 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
250 WEST MAIN STREET, SUITE 300, Charlottesville, VA, 22902
Phone
(434) 296-2675
Industry
Biotechnology
Entity type
Limited Liability Company
Incorporated in
Virginia
Revenue range
$1,000,001 - $5,000,000
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1842853

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jul 6, 2023New notice$5,000,000$1,800,000$3,200,0005Apr 28, 2023sec.gov
Dec 13, 2022New notice$5,000,000$1,110,000$3,890,0003Nov 14, 2022sec.gov
Jun 15, 2021New notice$5,000,000$350,000$4,650,0002May 20, 2021sec.gov
Feb 10, 2021New notice$500,000$500,0001Nov 6, 2019sec.gov
Jan 29, 2021New notice$4,000,000$1,030,000$2,970,0005Dec 31, 2020sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Peter LipskyExecutive Officer
Amrie GrammerExecutive Officer

Other biotechnology companies in Virginia that filed recently

Every Form D from the week of Jul 3, 2023 · All recent filings in Virginia · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Ampel, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.